Cargando…
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and hearing loss. A Combination of cisplatin with othe...
Autores principales: | Achkar, Iman W., Abdulrahman, Nabeel, Al-Sulaiti, Hend, Joseph, Jensa Mariam, Uddin, Shahab, Mraiche, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896132/ https://www.ncbi.nlm.nih.gov/pubmed/29642900 http://dx.doi.org/10.1186/s12967-018-1471-1 |
Ejemplares similares
-
Na(+)/H(+) Exchanger Isoform 1 Induced Cardiomyocyte Hypertrophy Involves Activation of p90 Ribosomal S6 Kinase
por: Jaballah, Maiy, et al.
Publicado: (2015) -
Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression
por: Abdulrahman, Nabeel, et al.
Publicado: (2022) -
p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer
por: Poomakkoth, Noufira, et al.
Publicado: (2016) -
Asterarcys quadricellulare (Chlorophyceae) protects H9c2 cardiomyoblasts from H(2)O(2)-induced oxidative stress
por: Saadaoui, Imen, et al.
Publicado: (2022) -
Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis
por: Abdelaziz Mohamed, Iman, et al.
Publicado: (2019)